← Back to Screener
China Pharma Holdings, Inc. (CPHI)
Price$0.72
Value ScoreD
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-64.00%
Price vs S&P 500 (4W)35.10%
VGM Score32.06
Market Capitalization$29.01M
All Metrics
P/CF (Annual)195.70x
Book Value / Share (Quarterly)$0.91
P/TBV (Annual)4.25x
Revenue Growth (3Y)-20.03%
Cash Flow / Share (Quarterly)$0.00
Price vs S&P 500 (YTD)-48.79%
Gross Margin (TTM)7.26%
Net Profit Margin (TTM)-88.82%
EPS (TTM)$-0.56
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-0.56
Revenue Growth (5Y)-17.53%
EPS (Annual)$-0.74
ROI (Annual)-12.19%
Gross Margin (Annual)-3.18%
Net Profit Margin (5Y Avg)-61.94%
Cash / Share (Quarterly)$0.00
Revenue Growth QoQ (YoY)-13.44%
ROA (Last FY)-10.28%
Revenue Growth TTM (YoY)-7.07%
EBITD / Share (TTM)$-0.21
ROE (5Y Avg)-53.11%
Operating Margin (TTM)-90.13%
Cash Flow / Share (Annual)$0.00
P/B Ratio0.78x
P/B Ratio (Quarterly)0.67x
Net Income / Employee (Annual)$-14,800
EV / Revenue (TTM)8.08x
Net Interest Coverage (TTM)-30.86x
ROA (TTM)-13.41%
EV / EBITDA (TTM)319.21x
EPS Incl Extra (Annual)$-0.74
Current Ratio (Annual)0.32x
Quick Ratio (Quarterly)0.06x
3-Month Avg Trading Volume0.22M
52-Week Price Return-56.68%
EV / Free Cash Flow (Annual)2928.27x
Revenue / Employee (TTM)$18,600
Tangible BV / Share (Quarterly)$0.01
P/S Ratio (Annual)7.00x
Asset Turnover (Annual)0.13x
52-Week High$2.05
Operating Margin (5Y Avg)-58.44%
EPS Excl Extra (Annual)$-0.74
CapEx CAGR (5Y)-30.83%
Tangible BV CAGR (5Y)-34.94%
26-Week Price Return-56.07%
Quick Ratio (Annual)0.09x
13-Week Price Return23.24%
Total Debt / Equity (Annual)0.15x
Current Ratio (Quarterly)0.28x
Enterprise Value$32.24M
Revenue / Share Growth (5Y)-40.04%
Asset Turnover (TTM)0.15x
Book Value / Share Growth (5Y)-30.10%
Revenue / Employee (Annual)$19,300
Inventory Turnover (Annual)2.20x
Pretax Margin (Annual)-76.91%
Cash / Share (Annual)$0.02
3-Month Return Std Dev174.56%
Gross Margin (5Y Avg)-10.70%
Net Income / Employee (TTM)$-16,500
ROE (Last FY)-14.02%
Net Interest Coverage (Annual)-34.82x
EPS Basic Excl Extra (Annual)$-0.74
P/FCF (TTM)67.89x
Receivables Turnover (TTM)15.20x
EV / Free Cash Flow (TTM)341.13x
Total Debt / Equity (Quarterly)0.09x
EPS Incl Extra (TTM)$-0.56
Receivables Turnover (Annual)17.50x
ROI (TTM)-16.09%
P/S Ratio (TTM)7.27x
Pretax Margin (5Y Avg)-61.94%
Revenue / Share (Annual)$0.97
Tangible BV / Share (Annual)$0.32
Price vs S&P 500 (52W)-81.05%
Year-to-Date Return-40.83%
5-Day Price Return-6.90%
EPS Normalized (Annual)$-0.74
ROA (5Y Avg)-19.63%
Net Profit Margin (Annual)-76.91%
Month-to-Date Return-9.78%
Cash Flow / Share (TTM)$-0.04
EBITD / Share (Annual)$-0.56
Operating Margin (Annual)-78.16%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)192.41x
ROI (5Y Avg)-28.41%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.56
P/TBV (Quarterly)266.86x
P/B Ratio (Annual)0.27x
Inventory Turnover (TTM)2.13x
Pretax Margin (TTM)-88.82%
Book Value / Share (Annual)$1.47
Price vs S&P 500 (13W)14.98%
Beta1.10x
P/FCF (Annual)2635.22x
Revenue / Share (TTM)$0.16
ROE (TTM)-19.02%
52-Week Low$0.38
vGradeD
gGradeD
mGradeC
vgmGradeD
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CPHIChina Pharma Holdings, Inc. | D | D | C | $0.72 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
China Pharma Holding Inc is a pharmaceutical manufacturer focused on treatments for high-incidence and high-mortality diseases in China. The company produces injectable medications, tablets, and capsules, including cephalosporin-based and specialty injectable products.